2026-04-25T05:32:20Z
https://www.pub.unibl.org/oai
oai:pub.unibl.org:30874
2025-12-19T04:43:51Z
Sorafenib as first line treatment for advanced liver cancer-are expiries
https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic
https://www.unibl.org/sr-lat/fis/zaposlen/3512-sasa-jungic
/unibl/author/Ivanka Rakita
/unibl/author/Radmila Rašeta
/unibl/author/G. Marić
/unibl/author/M. Vještica
/unibl/author/S. Mijatović
/unibl/author/S. Dašić
/unibl/author/M. Vižin
/unibl/author/Jelena Rožić
2012
Conference Paper
text
/unibl/sci/idNaucniRad:25642
https://dx.doi.org/10.1093/annonc/mds 153
14th World Congres of Gastrointestinal Cancer
This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista)
This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista)
Z. Gojković, S. Jungić, I. Rakita, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, S. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer-are expiries, This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista), 2012